Synfine Drugs Private Limited - Company Profile

It is a pharma private limited company based in Sangareddy, Telangana, India, established in 2017.
2017 Sangareddy, Telangana, India Active
Last Updated:
Access Report
About Synfine Drugs Private Limited

Synfine Drugs Private Limited, a active private limited company, was established on 20 March 2017 in Sangareddy, Telangana, India. Engaging in pharmaceutical retailers & distributors within the manufacturing sector, it holds CIN: U24304TG2017PTC116006. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹11.00 Cr and a paid-up capital of ₹4.87 Cr.

It upholds a compliant status. Employing 21 professional, Its leadership includes Saida Reddy Battu (Managing Director), Chandra Kala Battu (Director). It holds ₹11.00 Cr open charges and ₹9.51 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Survey No, 637, Temple Road, Bonthapally (Village) Gummadidala (Mandal), Sangareddy, Telangana, 502313.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24304TG2017PTC116006

  • Registration Number

    116006

  • Incorporation Date

    20 March 2017

  • Authorized Capital

    ₹11.00 Cr

  • Paid-Up Capital

    ₹4.87 Cr

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 11.00 Cr
  • Paid Up Capital ₹ 4.87 Cr
  • Company Age 9 Year, 3 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 11.00 Cr
  • Satisfied Charges ₹ 9.51 Cr
  • Revenue Growth **** 12.49%
  • Profit Growth **** 2472.93%
  • Ebitda **** 57.31%
  • Net Worth 29.72%
  • Total Assets -18.77%
Company report

Synfine Drugs Private Limited

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Synfine Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Synfine Drugs Private Limited?
Current Directors
Name Designation Appointment Date Status
Saida Reddy Battu Managing Director 20 Mar 2017 Current
Chandra Kala Battu Director 20 Mar 2017 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Synfine Drugs.

Synfine Drugs Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 12.49% increase. The company also saw a substantial improvement in profitability, with a 2472.93% increase in profit. The company's net worth Soared by an impressive increase of 29.72%.

Synfine Drugs revenue growth over time
Synfine Drugs profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 12.49%
*******
*******
*******
*******
Revenue from Operations
*******
 12.52%
*******
*******
*******
*******
Total Assets
*******
 -18.77%
*******
*******
*******
*******
Profit or Loss
*******
 2472.93%
*******
*******
*******
*******
Net Worth
*******
 29.72%
*******
*******
*******
*******
EBITDA
*******
 57.31%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Synfine Drugs?

In 2023, Synfine Drugs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹110,000,000.00

Satisfied Charges

₹95,100,000.00

Charges Breakdown by Lending Institutions
  • Others : 11.00 Cr
Latest Charge Details
Date Lender Amount Status
21 Nov 2024 Others ₹2.00 Cr Open
21 Nov 2024 Others ₹9.00 Cr Open
04 Sep 2019 State Bank Of India ₹9.51 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Synfine Drugs?

Synfine Drugs has a workforce of 21 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Synfine Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Synfine Drugs's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Synfine Drugs
Recent Activity within the Organization
  • Annual General Meeting

    Synfine Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    Progress on Synfine Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad. was documented.

  • Charges

    A charge with Others amounted to Rs. 2.00 Cr with Charge ID 101021956 was registered on 21 Nov 2024. was recorded as a recent event.

  • Charges

    Progress on A charge with Others amounted to Rs. 9.00 Cr with Charge ID 101022083 was registered on 21 Nov 2024. was documented.

  • Charges

    A charge registered on 04 Sep 2019 via Charge ID 100290357 with State Bank Of India was fully satisfied on 18 Nov 2024. was recorded as a recent event.

  • Charges

    A charge with State Bank Of India of Rs. 9.51 Cr registered on 04 Sep 2019 with Charge ID 100290357 was modified on 07 Jun 2023. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Synfine Drugs Private Limited?

The CIN of Synfine Drugs Private Limited is U24304TG2017PTC116006.

Where is Synfine Drugs Private Limited headquartered?

Synfine Drugs Private Limited is headquartered at Survey No, 637, Temple Road, Bonthapally (Village) Gummadidala (Mandal), Sangareddy, Telangana, 502313.

When was Synfine Drugs Private Limited incorporated?

Synfine Drugs Private Limited was incorporated on 20 March 2017.

Who are the current directors of Synfine Drugs Private Limited?

The current directors of Synfine Drugs Private Limited are

What is the primary industry of Synfine Drugs Private Limited?

The primary industry of Synfine Drugs Private Limited is Manufacturing.

Is Synfine Drugs Private Limited a listed company?

Synfine Drugs Private Limited is unlisted.

What is the capital structure of Synfine Drugs Private Limited?

The authorized capital of Synfine Drugs Private Limited is ₹11.00 Cr, and the paid-up capital is ₹4.87 Cr.

What is the compliance status of Synfine Drugs Private Limited?

The compliance status of Synfine Drugs Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available